KREBS BIOCHEMICALS & IND Share Price

NSE

Company Profile


Krebs Biochemicals & Industries Limited (KBIL) is an India-based company. Founded in 1991 with the main objective of establishing commercially viable biotech processes for application in medicine, agriculture, and industry, Krebs has been a pioneer in fermentation technology in India. In 1992, the company made its initial public offering and got listed on major stock exchanges such as the Hyderabad Stock Exchange Limited and the Bombay Stock Exchange Limited. It is currently manufacturing androstenedione, lovastatin, and simvastatin. The products that are currently in either pilot or research and development stages are amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine.

Return Calculator

This tools helps you project your potential returns on investments for the given stock, for a specified amount over a pre-defined period of time.

Invested amount

Investment period

1 year
2 year
5 year
=
up down
Returns
CAGR
%